AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Dec 09 2020
News
As Covid-19 Vaccines Roll Out, States to Determine Who Gets Shots First
The U.S. is about to launch one of the most daunting public-health efforts in generations: swiftly distributing a Covid-19 vaccine across all 50 states, each of which will determine who gets priority.
As soon as this weekend, the Food and Drug Administration is expected to grant emergency approval to a Covid-19 vaccine from Pfizer Inc. PFE -1.41% and BioNTech SE. BNTX -1.95% Within 24
Wall Street Journal (News)Sep 23 2020
News
Johnson & Johnson enters late-stage trial testing its coronavirus vaccine
Johnson & Johnson said Wednesday it has begun its phase three trial testing its potential coronavirus vaccine.
J&J is the fourth drugmaker backed by the Trump administration’s Covid-19 vaccine program Operation Warp Speed to enter late-stage testing. The others are Moderna, Pfizer and AstraZeneca.
The trial will enroll up to 60,000 adult volunteers across 215 locations in
CNBCDec 21 2020
Perspectives Blog
Weekly United News Roundup: Early Dec. Polls Found Americans of All Political Stripes Strongly Supported A New Coronavirus Stimulus Bill
Plus, a bipartisan “908 Coalition” and increased openness toward the vaccine
Congressional leaders announced an agreement on a $900 billion coronavirus relief bill Sunday night.
Polls conducted in early December found the desire for a new stimulus bill was shared among Democrats and Republicans alike. Republican enthusiasm somewhat lagged that of Democrats, but Republicans still
James CoanJan 28 2021
Headline Roundup
S. Africa COVID-19 Variant Detected In US; Vaccine Manufacturers Test Effectiveness Against It
The COVID-19 variant B.1351, first identified in South Africa, has been confirmed for the first time in the United States as vaccine developers test their drug's effectiveness against the new variant. The Svariant has raised concerns over being more contagious than other strains of the virus, and for potentially evading the immunity provided by antibodies. According to a release from the South
Reuters New York Post (News) Washington PostAug 18 2021
Headline Roundup
Booster Shots to Be Made Available to All Americans Starting Sept. 20
The Biden administration announced Wednesday that third shots of the Moderna and Pfizer-BioNTech COVID-19 vaccines will be made available to all Americans starting Sept. 20. The push for the third shots, commonly known as booster shots, comes alongside recent statements by vaccine makers and health experts that COVID-19 vaccines may be less effective after 6-8 months. Last week, the World
USA TODAY CNBC The Epoch TimesSep 12 2023
Headline Roundup
FDA Approves New Round of COVID-19 Vaccines
The United States Food and Drug Administration approved a new round of vaccines against COVID-19.
Key Quotes: According to a statement from the FDA, the new vaccines “more closely target currently circulating variants" and "provide better protection against serious consequences of COVID-19, including hospitalization and death." The FDA is "confident in the safety and effectiveness of
The Guardian Washington Examiner Wall Street Journal (News)Jan 22 2021
Analysis
What the Post-Insurrection Congressional Outbreak Tells Us About COVID-19 Vaccination
On Jan. 6, America watched in horror as insurrectionists attacked the Capitol. In real time, we followed the livestreamed video and images of angry mobs ransacking the building while lawmakers barricaded themselves in their offices and evacuated chambers in escape hoods. For a few hours, I was so chilled by the national crisis unfolding that I forgot it was all happening against the backdrop
SlateNov 19 2021
Headline Roundup
CDC Recommends Booster Shots for All Adults
A CDC advisory panel voted unanimously on Friday to recommend making all adults eligible for booster shots of the Pfizer or Moderna COVID-19 vaccine six months after their second dose. The panel also voted unanimously to strongly recommend that people over 50 should get a booster shot. In their deliberations, some panel members pointed to confusion over the current rules about who should get a
Washington Post New York Post (News) The HillMay 18 2020
Headline Roundup
Coronavirus Vaccine Trial Shows Positive Results
Moderna Inc., a biotech company based in Massachusetts, is reporting positive interim data in the first phase of a COVID-19 coronavirus vaccine trial, as immune responses are similar to that in people who had recovered from the disease.
The company is about to begin a phase two trial and hopes to start a phase three trial in July.
Newsmax (News) The Hill Washington PostApr 01 2021
Perspectives Blog
Story of the Week: White House Advances COVID-19 Vaccine Efforts, Developing Standards for 'Vaccine Passports'
Sign up here to receive the Story of the Week in your inbox every Thursday.
The Biden administration is working with the private sector to develop standards for proof-of-vaccination credentials, informally referred to by some as vaccine "passports." Such credentials could potentially be used by participating businesses to require customers be vaccinated against COVID-19. The
AllSides Staff